CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis
Gitte B. Christensen(Leo Pharma (Denmark)), Kaare Kemp(Leo Pharma (Denmark)), Malene Hvid(Aarhus University), Bent Deleuran(Aarhus University), Peter Helding Kvist(Leo Pharma (Australia)), Christian Vestergaard(Aarhus University), Mette Deleuran(Aarhus University Hospital)
Cited by 6
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
|PEDIATRICS|2009|409
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377